BETTA PHARMACEUTICALS: Has reached a strategic cooperation with Boryung Biopharma, and the company’s exclusive distribution of Anruize has officially launched nationwide sales

BETTA PHARMACEUTICALS announced that the company has reached a strategic cooperation with Hangzhou Bozhirui Biopharmaceutical Co., Ltd. to acquire the project rights for Pertuzumab Injection and has been granted the distribution rights for Trastuzumab Injection in China. The nationwide sales of Anruize, which is exclusively distributed by the company, have officially commenced, positively impacting the company's future operating income. The cooperation on "Dual Antibody" is another strategic collaboration following the Beianting project, marking the company's comprehensive commercial layout in the breast cancer field after its deep cultivation in the treatment areas of lung cancer and kidney cancer, which is beneficial for enriching the company's commercial product pipeline and further expanding the disease treatment areas